Literature DB >> 31412600

Structural and Biological Characterizations of Novel High-Affinity Fluorescent Probes with Overlapped and Distinctive Binding Regions on CXCR4.

Siyu Zhu1,2, Qian Meng1, Robert T Schooley2, Jing An2, Yan Xu3, Ziwei Huang4,5.   

Abstract

CXC-type chemokine receptor 4 (CXCR4) is well known as a co-receptor for cellular entry and infection of human immunodeficiency virus type 1 (HIV-1). As an important member of the G protein-coupled receptor (GPCR) family, CXCR4 also mediates a variety of cellular processes and functions, such as cell chemotaxis, proliferation, and calcium signal transductions. Identification and characterization of molecular ligands or probes of CXCR4 have been an intensive area of investigations as such ligands or probes are of significant clinical values for the studies and treatments of HIV-1 infection and other human diseases mediated by the receptor. The crystal structures of CXCR4 in complex with different ligands have revealed two distinctive binding regions or subpockets. Thus, understanding the interactions of diverse ligands with these distinctive CXCR4 binding regions has become vital for elucidating the relationship between binding modes and biological mechanisms of ligand actions. Peptidic CVX15 is the only ligand that has been validated to bind one of these distinctive binding regions (or so called the major subpocket) of CXCR4. Therefore, in this study, we developed an efficient probe system including two high-affinity peptidic fluorescent probes, designated as FITC-CVX15 and FITC-DV1, with the aim of targeting distinctive CXCR4 subpockets. We conducted rational design and chemical characterization of the two CXCR4-specific probes and examined their application in biological experiments including competitive binding assays, flow cytometry analysis, and confocal imaging. Especially these two probes were applied in parallel CXCR4 competitive binding assays to detect and analyze potential binding modes of diverse CXCR4 ligands, together with molecular docking and simulations. Our results have indicated that these peptidic fluorescent probe systems provide novel ligand detecting tools, as well as present a new approach for analyzing distinctive binding modes of diverse CXCR4 ligands.

Entities:  

Keywords:  CXC-type chemokine receptor 4 (CXCR4); HIV-1 infection; cancer metastasis; competitive ligand binding; distinct subpockets; fluorescent peptidic probes; molecular docking simulations

Mesh:

Substances:

Year:  2019        PMID: 31412600      PMCID: PMC6720714          DOI: 10.3390/molecules24162928

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  53 in total

Review 1.  Chemokine receptor trafficking and viral replication.

Authors:  A Pelchen-Matthews; N Signoret; P J Klasse; A Fraile-Ramos; M Marsh
Journal:  Immunol Rev       Date:  1999-04       Impact factor: 12.988

2.  Role of CXCR4 in HIV-1-induced apoptosis of cells with a CD4+, CXCR4+ phenotype.

Authors:  M Biard-Piechaczyk; V Robert-Hebmann; J Roland; N Coudronnière; C Devaux
Journal:  Immunol Lett       Date:  1999-10-01       Impact factor: 3.685

3.  Exploring the stereochemistry of CXCR4-peptide recognition and inhibiting HIV-1 entry with D-peptides derived from chemokines.

Authors:  Naiming Zhou; Zhaowen Luo; Jiansong Luo; Xuejun Fan; Mark Cayabyab; Megumi Hiraoka; Dongxiang Liu; Xiaobing Han; James Pesavento; Chang-Zhi Dong; Youli Wang; Jing An; Hideko Kaji; Joseph G Sodroski; Ziwei Huang
Journal:  J Biol Chem       Date:  2002-03-05       Impact factor: 5.157

Review 4.  Structure, function and modulation of chemokine receptors: members of the g-protein-coupled receptor superfamily.

Authors:  Ziwei Huang
Journal:  Mini Rev Med Chem       Date:  2002-08       Impact factor: 3.862

5.  Characterization and visualization of [125I] stromal cell-derived factor-1alpha binding to CXCR4 receptors in rat brain and human neuroblastoma cells.

Authors:  G Banisadr; E Dicou; T Berbar; W Rostène; A Lombet; F Haour
Journal:  J Neuroimmunol       Date:  2000-10-02       Impact factor: 3.478

6.  Molecular-size reduction of a potent CXCR4-chemokine antagonist using orthogonal combination of conformation- and sequence-based libraries.

Authors:  Nobutaka Fujii; Shinya Oishi; Kenichi Hiramatsu; Takanobu Araki; Satoshi Ueda; Hirokazu Tamamura; Akira Otaka; Shuichi Kusano; Shigemi Terakubo; Hideki Nakashima; James A Broach; John O Trent; Zi-xuan Wang; Stephen C Peiper
Journal:  Angew Chem Int Ed Engl       Date:  2003-07-21       Impact factor: 15.336

7.  Involvement of chemokine receptors in breast cancer metastasis.

Authors:  A Müller; B Homey; H Soto; N Ge; D Catron; M E Buchanan; T McClanahan; E Murphy; W Yuan; S N Wagner; J L Barrera; A Mohar; E Verástegui; A Zlotnik
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

8.  A novel peptide antagonist of CXCR4 derived from the N-terminus of viral chemokine vMIP-II.

Authors:  N Zhou; Z Luo; J Luo; J W Hall; Z Huang
Journal:  Biochemistry       Date:  2000-04-04       Impact factor: 3.162

9.  Antigenically distinct conformations of CXCR4.

Authors:  F Baribaud; T G Edwards; M Sharron; A Brelot; N Heveker; K Price; F Mortari; M Alizon; M Tsang; R W Doms
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

10.  The role of positively charged residues in CXCR4 recognition probed with synthetic peptides.

Authors:  Z Luo; N Zhou; J Luo; J W Hall; Z Huang
Journal:  Biochem Biophys Res Commun       Date:  1999-10-05       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.